670 related articles for article (PubMed ID: 36032075)
21. Cancer-associated fibroblast spatial heterogeneity and
Honda CK; Kurozumi S; Fujii T; Pourquier D; Khellaf L; Boissiere F; Horiguchi J; Oyama T; Shirabe K; Colinge J; Yokobori T; Turtoi A
Theranostics; 2024; 14(5):1873-1885. PubMed ID: 38505604
[No Abstract] [Full Text] [Related]
22. Cancer-associated fibroblast-associated gene IGFBP2 promotes glioma progression through induction of M2 macrophage polarization.
Zhang X; Sun X; Guo C; Li J; Liang G
Am J Physiol Cell Physiol; 2024 Jan; 326(1):C252-C268. PubMed ID: 37982173
[TBL] [Abstract][Full Text] [Related]
23. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
24. Identification of prognostic cancer-associated fibroblast markers in luminal breast cancer using weighted gene co-expression network analysis.
Xu A; Xu XN; Luo Z; Huang X; Gong RQ; Fu DY
Front Oncol; 2023; 13():1191660. PubMed ID: 37207166
[TBL] [Abstract][Full Text] [Related]
25. A comprehensive multi-omics analysis identifies a robust scoring system for cancer-associated fibroblasts and intervention targets in colorectal cancer.
Wang F; Li Z; Xu T; Zhang Q; Ma T; Li S; Wang X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):124. PubMed ID: 38478111
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive profiling of endocrine metabolism identifies a novel signature with robust predictive value in ovarian cancer.
Yu D; Luo Y; Guo R; Ma F; Chang Y; Dang J
J Gene Med; 2024 May; 26(5):e3686. PubMed ID: 38689382
[TBL] [Abstract][Full Text] [Related]
27. Integration of single-cell RNA-seq and bulk RNA-seq data to construct and validate a cancer-associated fibroblast-related prognostic signature for patients with ovarian cancer.
Shen L; Li A; Cui J; Liu H; Zhang S
J Ovarian Res; 2024 Apr; 17(1):82. PubMed ID: 38627854
[TBL] [Abstract][Full Text] [Related]
28. A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer.
Ge W; Yue M; Wang Y; Wang Y; Xue S; Shentu D; Mao T; Zhang X; Xu H; Li S; Ma J; Wang L; Cui J
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613599
[TBL] [Abstract][Full Text] [Related]
29. The Cancer-Associated Fibroblasts-Related Gene COMP Is a Novel Predictor for Prognosis and Immunotherapy Efficacy and Is Correlated with M2 Macrophage Infiltration in Colon Cancer.
Ma H; Qiu Q; Tan D; Chen Q; Liu Y; Chen B; Wang M
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671447
[TBL] [Abstract][Full Text] [Related]
30. GPX8
Bai Y; Han T; Dong Y; Liang C; Gao L; Liu Y; Zhou J; Guo J; Ge D; Wu J; Hu D
BMC Med Genomics; 2024 Mar; 17(1):77. PubMed ID: 38515109
[TBL] [Abstract][Full Text] [Related]
31. Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma.
Truxova I; Cibula D; Spisek R; Fucikova J
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822672
[TBL] [Abstract][Full Text] [Related]
32. Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer.
Li C; Yang L; Zhang Y; Hou Q; Wang S; Lu S; Tao Y; Hu W; Zhao L
Front Immunol; 2023; 14():1307588. PubMed ID: 38235137
[TBL] [Abstract][Full Text] [Related]
33. Characterization of tumor microenvironment and programmed death-related genes to identify molecular subtypes and drug resistance in pancreatic cancer.
Yu L; He R; Cui Y
Front Pharmacol; 2023; 14():1146280. PubMed ID: 37007021
[No Abstract] [Full Text] [Related]
34. Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.
Liu J; Xu W; Li S; Sun R; Cheng W
Int J Med Sci; 2020; 17(18):3200-3213. PubMed ID: 33173439
[No Abstract] [Full Text] [Related]
35. Cancer-Associated Fibroblast Risk Model for Prediction of Colorectal Carcinoma Prognosis and Therapeutic Responses.
Wang Y; Chen Z; Zhao G; Li Q
Mediators Inflamm; 2023; 2023():3781091. PubMed ID: 37144239
[TBL] [Abstract][Full Text] [Related]
36. Deciphering tumor immune microenvironment differences between high-grade serous and endometrioid ovarian cancer to investigate their potential in indicating immunotherapy response.
Yang H; Gu X; Fan R; Zhu Q; Zhong S; Wan X; Chen Q; Zhu L; Feng F
J Ovarian Res; 2023 Nov; 16(1):223. PubMed ID: 37993916
[TBL] [Abstract][Full Text] [Related]
37. Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer.
Zheng S; Zou Y; Tang Y; Yang A; Liang JY; Wu L; Tian W; Xiao W; Xie X; Yang L; Xie J; Wei W; Xie X
Oncoimmunology; 2022; 11(1):2020984. PubMed ID: 35003899
[TBL] [Abstract][Full Text] [Related]
38. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer.
Li X; Sun Z; Peng G; Xiao Y; Guo J; Wu B; Li X; Zhou W; Li J; Li Z; Bai C; Zhao L; Han Q; Zhao RC; Wang X
Theranostics; 2022; 12(2):620-638. PubMed ID: 34976204
[No Abstract] [Full Text] [Related]
39. Bioinformatic analysis of cancer-associated fibroblast related gene signature as a predictive model in clinical outcomes and immune characteristics of gastric cancer.
Zhang J; Zhang N; Fu X; Wang W; Liu H; McKay MJ; Dejkriengkraikul P; Nie Y
Ann Transl Med; 2022 Jun; 10(12):698. PubMed ID: 35845527
[TBL] [Abstract][Full Text] [Related]
40. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
